NCT04953312 2026-03-12
CALPRO
Assistance Publique - Hôpitaux de Paris
Phase NA Withdrawn
Clinical Trials
19 trialsNCT04565665 2026-03-10
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
NCT05672355 2026-03-05
A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia
City of Hope Medical Center
Phase 2 Recruiting
NCT07450833 2026-03-05
BOOST
Benfovir AG
Phase 1 Completed
NCT03830320 2026-02-27
Positron Emission Tomography (PET) Imaging of Thrombosis
Massachusetts General Hospital
Phase 1 Recruiting
NCT04977024 2026-02-11
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
GeoVax, Inc.
Phase 2 Active not recruiting
NCT05119855 2026-02-05
Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT04421625 2025-12-30
PAPESCO-19
Institut Cancerologie de l'Ouest
Phase NA Completed
NCT04442048 2025-12-30
COV-IMMUNO
Canadian Cancer Trials Group
Phase 3 Completed
NCT04425616 2025-12-02
SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer
University Hospital Southampton NHS Foundation Trust
Phase NA Completed
NCT05102656 2025-11-17
Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT04492410 2025-09-30
NEOSCREENCOVID
Centre Antoine Lacassagne
Phase NA Completed
NCT05120869 2025-09-04
Healthcare Provider Human Papillomavirus Education and Professional Skills Intervention
University of Texas, El Paso
Phase NA Completed
NCT05655546 2025-08-08
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Scripps Translational Science Institute
Phase NA Terminated
NCT04870333 2025-06-20
PROTECT-V
Cambridge University Hospitals NHS Foundation Trust
Phase 2/3 Completed
NCT03305341 2025-06-11
COVSP-BCG
Medicine Invention Design, Inc
Phase EARLY_PHASE1 Active not recruiting
NCT04377659 2025-05-28
Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection
Memorial Sloan Kettering Cancer Center
Phase 2 Terminated
NCT04347226 2025-05-22
Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19
Columbia University
Phase 2 Terminated
NCT06124131 2025-05-04
BENEFIT-C
Tulane University
Phase NA Completed